Tat is essential for viral replication and functions primarily by enhancing transcription elongation from the HIV promoter [68-72]. At the start of this project. Tat was known to recruit the heterodimeric kinase, P-TEFb, composed of CycTI (cyclin Tl) and Cdk9 subunits, to the TAR RNA element at the 5' end of nascent HIV transcripts, triggering RNA Pol II CTD phosphorylation and transcriptional elongation [70, 73, 74]. The recent crystal structure of a Tat-P-TEFb complex [75] was an important step forward, showing how both the CycTI and Cdk9 partners are required to template Tat structure. An immediate challenge is to define how the Tat-PTEFb complex regulates transcription. Two HARC Center discoveries changed the basic P-TEFb paradigm and provided new hypotheses that we will test. First using our proteomics pipeline, we found that Tat selectively recruits P-TEFb as part of a large, stoichiometric complex containing additional transcription elongation factors [3, 76] This complex has been called the super elongation complex (SEC) [77] and the MLL-fusion complex to reflect its role in promoting certain leukemias [78]. Here we refer to it as AFF4c to reflect the central scaffolding role of the AFF4 protein. Remarkably, AFF4c is not only part of a combinatorial family of related assemblies (AFFcs), but it also is normally recruited to only a subset of human genes occupied by paused polymerases [77-80]. This raises the question of the origin of the specificity of AFF4 assembly and recruitment which we aim to address. Second, we found that Tat assembles at the HIV promoter along with an inactive, 7SK snRNP-associated form of PTEFb [70] which is dismantled upon TAR binding [4]. By dissecting the host complexes recruited by Tat we will fill major gaps in understanding HIV and host transcription. This mechanistic insight is needed to target Tat with therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
4P50GM082250-10
Application #
9135473
Study Section
Special Emphasis Panel (ZRG1-AARR-K)
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
10
Fiscal Year
2016
Total Cost
$176,233
Indirect Cost
$57,345
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Chen, Si-Han; Jang, Gwendolyn M; Hüttenhain, Ruth et al. (2018) CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. EMBO J 37:
Leoz, Marie; Kukanja, Petra; Luo, Zeping et al. (2018) HEXIM1-Tat chimera inhibits HIV-1 replication. PLoS Pathog 14:e1007402
Cheng, Yifan (2018) Single-particle cryo-EM-How did it get here and where will it go. Science 361:876-880
Roth, Theodore L; Puig-Saus, Cristina; Yu, Ruby et al. (2018) Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559:405-409
Ferdin, Jana; Gori?ar, Katja; Dolžan, Vita et al. (2018) Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA. PLoS One 13:e0191613
Cheng, Yifan (2018) Membrane protein structural biology in the era of single particle cryo-EM. Curr Opin Struct Biol 52:58-63
Ivry, Sam L; Meyer, Nicole O; Winter, Michael B et al. (2018) Global substrate specificity profiling of post-translational modifying enzymes. Protein Sci 27:584-594
Cary, Daniele C; Peterlin, B Matija (2018) Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1. PLoS One 13:e0208055
Palovcak, Eugene; Wang, Feng; Zheng, Shawn Q et al. (2018) A simple and robust procedure for preparing graphene-oxide cryo-EM grids. J Struct Biol 204:80-84
Tambe, Akshay; East-Seletsky, Alexandra; Knott, Gavin J et al. (2018) RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a. Cell Rep 24:1025-1036

Showing the most recent 10 out of 199 publications